The Public Should Have A Say In Subsidizing Patient Cost For New Expensive Drugs
Only recently has conversation about access to new drugs been moving to acknowledging the need for a community debate about affordability as well. pixxiestails, CC BY-NC
By Sally Wortley, University of Sydney and Deme Karikios, University of Sydney
Decisions about public subsidies for high-cost drugs are naturally quite complex. And while patients have increasingly been given a voice in the process, the views of the wider community have generally not been sought. But given the rising cost of new drugs, perhaps it’s time to widen the discussion and start a debate about equity and the…